Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics

Nasopharyngeal carcinoma (NPC) is a malignant cancer type with high morbidity in Asia, and its current molecular classification is insufficient to predict therapy outcomes. Here the authors explore NPC subtype-specific response to therapy with a pharmacogenomics strategy integrating genomics and dru...

Full description

Bibliographic Details
Main Authors: Ren-Bo Ding, Ping Chen, Barani Kumar Rajendran, Xueying Lyu, Haitao Wang, Jiaolin Bao, Jianming Zeng, Wenhui Hao, Heng Sun, Ada Hang-Heng Wong, Monica Vishnu Valecha, Eun Ju Yang, Sek Man Su, Tak Kan Choi, Shuiming Liu, Kin Iong Chan, Ling-Lin Yang, Jingbo Wu, Kai Miao, Qiang Chen, Joong Sup Shim, Xiaoling Xu, Chu-Xia Deng
Format: Article
Language:English
Published: Nature Publishing Group 2021-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-23379-3
id doaj-87f829886bef4facb841e43c9c543db3
record_format Article
spelling doaj-87f829886bef4facb841e43c9c543db32021-05-30T11:13:17ZengNature Publishing GroupNature Communications2041-17232021-05-0112111910.1038/s41467-021-23379-3Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomicsRen-Bo Ding0Ping Chen1Barani Kumar Rajendran2Xueying Lyu3Haitao Wang4Jiaolin Bao5Jianming Zeng6Wenhui Hao7Heng Sun8Ada Hang-Heng Wong9Monica Vishnu Valecha10Eun Ju Yang11Sek Man Su12Tak Kan Choi13Shuiming Liu14Kin Iong Chan15Ling-Lin Yang16Jingbo Wu17Kai Miao18Qiang Chen19Joong Sup Shim20Xiaoling Xu21Chu-Xia Deng22Cancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauKiang Wu HospitalKiang Wu HospitalDepartment of Oncology, The Affiliated Hospital of Southwest Medical UniversityDepartment of Oncology, The Affiliated Hospital of Southwest Medical UniversityCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauCancer Centre, Faculty of Health Sciences, University of MacauNasopharyngeal carcinoma (NPC) is a malignant cancer type with high morbidity in Asia, and its current molecular classification is insufficient to predict therapy outcomes. Here the authors explore NPC subtype-specific response to therapy with a pharmacogenomics strategy integrating genomics and drug response of patient-derived organoids.https://doi.org/10.1038/s41467-021-23379-3
collection DOAJ
language English
format Article
sources DOAJ
author Ren-Bo Ding
Ping Chen
Barani Kumar Rajendran
Xueying Lyu
Haitao Wang
Jiaolin Bao
Jianming Zeng
Wenhui Hao
Heng Sun
Ada Hang-Heng Wong
Monica Vishnu Valecha
Eun Ju Yang
Sek Man Su
Tak Kan Choi
Shuiming Liu
Kin Iong Chan
Ling-Lin Yang
Jingbo Wu
Kai Miao
Qiang Chen
Joong Sup Shim
Xiaoling Xu
Chu-Xia Deng
spellingShingle Ren-Bo Ding
Ping Chen
Barani Kumar Rajendran
Xueying Lyu
Haitao Wang
Jiaolin Bao
Jianming Zeng
Wenhui Hao
Heng Sun
Ada Hang-Heng Wong
Monica Vishnu Valecha
Eun Ju Yang
Sek Man Su
Tak Kan Choi
Shuiming Liu
Kin Iong Chan
Ling-Lin Yang
Jingbo Wu
Kai Miao
Qiang Chen
Joong Sup Shim
Xiaoling Xu
Chu-Xia Deng
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
Nature Communications
author_facet Ren-Bo Ding
Ping Chen
Barani Kumar Rajendran
Xueying Lyu
Haitao Wang
Jiaolin Bao
Jianming Zeng
Wenhui Hao
Heng Sun
Ada Hang-Heng Wong
Monica Vishnu Valecha
Eun Ju Yang
Sek Man Su
Tak Kan Choi
Shuiming Liu
Kin Iong Chan
Ling-Lin Yang
Jingbo Wu
Kai Miao
Qiang Chen
Joong Sup Shim
Xiaoling Xu
Chu-Xia Deng
author_sort Ren-Bo Ding
title Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
title_short Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
title_full Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
title_fullStr Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
title_full_unstemmed Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
title_sort molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2021-05-01
description Nasopharyngeal carcinoma (NPC) is a malignant cancer type with high morbidity in Asia, and its current molecular classification is insufficient to predict therapy outcomes. Here the authors explore NPC subtype-specific response to therapy with a pharmacogenomics strategy integrating genomics and drug response of patient-derived organoids.
url https://doi.org/10.1038/s41467-021-23379-3
work_keys_str_mv AT renboding molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT pingchen molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT baranikumarrajendran molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT xueyinglyu molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT haitaowang molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT jiaolinbao molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT jianmingzeng molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT wenhuihao molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT hengsun molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT adahanghengwong molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT monicavishnuvalecha molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT eunjuyang molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT sekmansu molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT takkanchoi molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT shuimingliu molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT kiniongchan molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT linglinyang molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT jingbowu molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT kaimiao molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT qiangchen molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT joongsupshim molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT xiaolingxu molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
AT chuxiadeng molecularlandscapeandsubtypespecifictherapeuticresponseofnasopharyngealcarcinomarevealedbyintegrativepharmacogenomics
_version_ 1721420611295641600